DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Moehler M, Shitara K, Garrido M. et al.
Nivolumab (Nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastro-esophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): first results of the CheckMate 649 study.
Ann Oncol 2020;
31 (Suppl. 04) S1142-S1215
Access:
We do not assume any responsibility for the contents of the web pages of other providers.